Plain-English translation of NCT07117162 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to help veterans with early memory loss or mild dementia get faster access to care and newer treatments. Instead of waiting for a specialist appointment to start testing, participants will complete memory screening and blood work ahead of time using telehealth (video visits). This could help doctors figure out who might benefit from amyloid targeting therapies—newer medications designed to slow memory decline—much more quickly.
Many veterans with early memory problems have to wait a long time for specialist appointments and testing, which delays their chance to start treatment that could help. This trial is testing whether doing some screening and blood work before the specialist visit can speed things up and get more veterans access to these newer treatments.
You likely qualify if…
You likely don't qualify if…
If you're chosen for this study, you'll be randomly placed in one of two groups. One group will do memory screening and blood work by telehealth (video visit) before meeting with a memory specialist—this helps doctors prepare and move faster. The other group will do usual care, with all testing and visits scheduled by the specialist as normal. Either way, you'll be working toward finding out if you're a good candidate for newer memory-loss treatments.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
United States